St. Jude Medical, Inc. (NYSE: STJ) Gains As Abbott Plans Purchase

St. Jude Medical, Inc.

shares climbed 3.5% to $71.73 following the FT report indicating that Abbott Laboratories is working on a $25-billion bid for the company. Share volume totaled 393,000, compared to an all-day average of 406,000